BIOMAT Database Logo BIOMAT Database Logo

Gemcitabine-induced pulmonary toxicity: case report and review of the literature. 2002

Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Division of Hematology/Oncology, Department of Medicine, Long Island Jewish Medical Center, 270-05 76 Avenue, New Hyde Park, NY 11042, U.S.A.

Gemcitabine is a pyrimidine analog with a similar chemical structure and mechanism of action, as cytarabine. It has been shown to be a highly active agent for non-small cell lung cancer, pancreatic cancer, urothelial cancer, breast cancer and ovarian cancer. Gemcitabine is relatively well tolerated and myelosuppression is the dose-limiting toxicity. Pulmonary toxicity with gemcitabine is relatively uncommon, but a well recognized entity, associated with significant morbidity and mortality. A high index of suspicion, early diagnosis and timely intervention with oxygen supplementation, steroids, and diuretics is necessary to manage patients with this complication.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000093542 Gemcitabine A deoxycytidine antimetabolite used as an antineoplastic agent. 2',2'-Difluoro-2'-Deoxycytidine,2',2'-Difluorodeoxycytidine,2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate,2'-Deoxy-2'-Difluorocytidine,Gemcitabine Hydrochloride,Gemcitabine, (D-threo-pentafuranosyl)-Isomer,Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer,Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer,Gemicitabine,2',2'-DFDC,Gemzar,LY 188011,LY-188011,dFdCyd,188011, LY,2' Deoxy 2' Difluorocytidine,2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate,Hydrochloride, Gemcitabine
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D017563 Lung Diseases, Interstitial A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. Diffuse Parenchymal Lung Disease,Diffuse Parenchymal Lung Diseases,Interstitial Lung Disease,Interstitial Lung Diseases,Pneumonia, Interstitial,Pneumonitis, Interstitial,Interstitial Pneumonia,Interstitial Pneumonias,Interstitial Pneumonitides,Interstitial Pneumonitis,Lung Disease, Interstitial,Pneumonias, Interstitial,Pneumonitides, Interstitial

Related Publications

Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Mitomycin-induced pulmonary toxicity: case report and review of the literature.
April 1992, The Annals of pharmacotherapy,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature.
January 2018, Case reports in medicine,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Bortezomib induced pulmonary toxicity: a case report and review of the literature.
January 2020, American journal of blood research,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Nitrofurantoin-induced pulmonary toxicity: A case report and review of the literature.
January 2015, Journal of infection and public health,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Amiodarone-induced pulmonary toxicity--a fatal case report and literature review.
June 2013, Cardiovascular drugs and therapy,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease.
January 2015, Clinical Medicine Insights. Oncology,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Gemcitabine induced pneumonitis: a case report and review of literature.
October 2020, Journal of community hospital internal medicine perspectives,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Gemcitabine-induced cardiomyopathy: a case report and review of the literature.
June 2014, Journal of medical case reports,
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
October 2019, Current oncology (Toronto, Ont.),
Niraj Gupta, and Imran Ahmed, and Harry Steinberg, and Dilip Patel, and Sandy Nissel-Horowitz, and Bhoomi Mehrotra
Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature.
January 2018, Case reports in oncology,
Copied contents to your clipboard!